Sign Out
Mirabegron (Betmiga) is contraindicated in patients with: Hypersensitivity to the active substance or to any of the excipients listed in Description.
Severe uncontrolled hypertension defined as systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg.
